Results 61 to 70 of about 2,582 (154)

Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT

Case Reports in Oncology, 2021
We report a 49-year-old male with castration-resistant prostate cancer (CRPC) with oligometastasis diagnosed by 11C-choline positron emission tomography-computed tomography (PET/CT) and treated with target radiotherapy.
Kazuhiro Kitajima, Shingo Yamamoto, Masayuki Fujiwara, Hitomi Suzuki, Nahomi Yoshimura, Ryo Kunimoto, Hiroyuki Yokoyama, Hisashi Komoto, Yusuke Yamada, Seiji Nagasawa, Akihiro Kanematsu, Ryoong-Jin Oh, Koichiro Yamakado   +12 more
doaj   +1 more source

Percutaneous Cryoablation Under Local Anesthesia for Pulmonary Metastases From Colorectal Cancer: Long‐Term Outcomes From a Single‐Institution Retrospective Cohort

Cancer Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background Surgical resection is the standard treatment for pulmonary metastases from colorectal cancer, but its safety and long‐term efficacy in medically inoperable patients remain limited. Percutaneous cryoablation is a minimally invasive alternative to surgical resection and has gained increasing attention in recent years.
Shun Yorimori, Kaoru Kaseda, Yusuke Aoki, Kosuke Sugino, Takahiro Suzuki, Yu Okubo, Shigeki Suzuki, Kyohei Masai, Masashi Tamura, Masanori Inoue, Hideki Yashiro, Seishi Nakatsuka, Yoshikane Yamauchi, Yotaro Izumi, Masafumi Kawamura, Masahiro Jinzaki, Keisuke Asakura   +16 more
wiley   +1 more source

Clinical and genomic characterization of pancreatic ductal adenocarcinoma patients with lung oligometastasis

ESMO Gastrointestinal Oncology, 2023
Background: Lung-only relapse following resection of pancreatic ductal adenocarcinoma (PDAC) is rare. While oligometastatic lung disease (OMLD) is detected after PDAC resection, its clinical and molecular features remain unclear.
N.S. Tissera, M. Chiaravalli, A. Turpin, R. Luca, F. Castet, C. Fabregat-Franco, G. Castillo, D. López-Valbuena, G. Tortora, P. Hammel, J.M. O’Connor, J. Matito, A. Vivancos, T.V. Tian, T. Macarulla   +14 more
doaj   +1 more source

Addition of Immune Checkpoint Inhibitor to Platinum Retreatment for Recurrent Non‐Small Cell Lung Cancer After Perioperative Chemotherapy: A Multicenter Retrospective Study

Thoracic Cancer, Volume 17, Issue 7, April 2026.
We retrospectively analyzed 31 patients with NSCLC treated with platinum retreatment who relapsed after perioperative platinum therapy and surgery. PFS was significantly longer in the ICI‐chemo group than in the chemo group. Adding ICI to platinum retreatment may be an effective option for this population.
Toshiaki Takakura, Ryota Shibaki, Atsushi Washioka, Yusuke Murakami, Yuhei Harutani, Hiroaki Akamatsu, Nobuyuki Yamamoto   +6 more
wiley   +1 more source

Making Difficult Decisions in Lung Cancer: Oligometastasis, Ground Glass Opacities, Bilateral Lung Lesions, Surgery for Recurrence

, 2018
Gilbert Massard of the Centre Hospitalier in Strasbourg, France, discusses difficult treatment decisions in lung cancer. He reviews the different treatment approaches for oligometastasis, ground glass opacities, and multiple primary lung cancers, and ...
Gilbert Massard (5451137)
core   +1 more source

Conversion Therapy for cT4b and M1 Esophageal Squamous Cell Carcinoma: A Comprehensive Systematic Review

Annals of Gastroenterological Surgery, Volume 10, Issue 2, Page 294-304, March 2026.
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley   +1 more source

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report

, 2018
Background Long-term survival after resection of metastases from pancreatic ductal adenocarcinoma is rare. Case presentation A 54-year-old man underwent pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) with UICC staging pT3N1M0 ...
Hidefumi Takei, Junji Furuse, Haruhiko Kondo, Masachika Fujiwara, Junji Shibahara, Ryota Matsuki, Masanori Sugiyama   +6 more
core   +1 more source

Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma

, 2022
© 2022 S. Karger AG, Basel. Copyright: All rights reserved.Introduction: The aim of this study was to investigate the clinical outcomes of metastasis-directed therapy (MDT) using stereotactic body radiotherapy (SBRT) in patients with synchronous or ...
Guler Yavas, Burak Tilki, Ozan Cem Guler, ÖZYİĞİT, GÖKHAN, Oymak, Ezgi, Onal, Cem, Guler, Ozan Cem, HÜRMÜZ, PERVİN, Yavas, Cagdas, Yavas, Guler, Cem Onal, TİLKİ, BURAK, Cagdas Yavas, Ezgi Oymak, Pervin Hurmuz, Gokhan Ozyigit   +15 more
core   +1 more source

Case Report: Endoscopic submucosal dissection revealed isolated gastric metastasis from primary bladder urothelial carcinoma: clinicopathological analysis and literature review

Frontiers in Medicine
A 73-year-old male was admitted to our department with complaints of upper abdominal distension, accompanied by dull pain and belching for more than 10 days.
Famei Xu, Guihua Li, Guihong Qiu, Hongbo Yu, Qing Yin, Fabao Xu, Tianzi Jian   +6 more
doaj   +1 more source

MicroRNA expression characterizes oligometastasis(es). [PDF]

PLoS ONE, 2011
Cancer staging and treatment presumes a division into localized or metastatic disease. We proposed an intermediate state defined by ≤ 5 cumulative metastasis(es), termed oligometastases.
Yves A Lussier, H Rosie Xing, Joseph K Salama, Nikolai N Khodarev, Yong Huang, Qingbei Zhang, Sajid A Khan, Xinan Yang, Michael D Hasselle, Thomas E Darga, Renuka Malik, Hanli Fan, Samantha Perakis, Matthew Filippo, Kimberly Corbin, Younghee Lee, Mitchell C Posner, Steven J Chmura, Samuel Hellman, Ralph R Weichselbaum   +19 more
doaj   +1 more source